Biocytogen (HKEX: 02315), a global biotech company dedicated to discovering and developing novel antibody therapeutics, ...

Oxford, UK and San Jose, California, 9 January 2024 - (OBT), a clinical stage oncology company with a pipeline of ...

A novel class of antibodies that binds to a previously untargeted portion of the malaria parasite could lead to new ...

Novel antibodies have the potential to pave the way for the next generation of malaria interventions. Researchers at the ...

Antibodies that bind to a previously untargeted portion of the malaria parasite could lead to new monoclonal antibody treatments and vaccines for malaria.

NIH researchers discover novel class of antibodies that could lead to next generation of interventions against malaria.

Christopher P. Molineaux, President and CEO, Life Sciences Pennsylvania When we spoke in January 2024, you described a “pall” ...

Vir Biotechnology's recent share price rally is driven by their promising cancer program. Having shot to over a $1.5B market ...

Agreement supports the research and development of up to five novel therapeutic antibodies identified through Alchemab's antibody discovery platform. CAMBRIDGE, England, Jan. 9, 2025 /PRNewswire/ ...

NIH Researchers Discover Novel Class of Anti-Malaria Antibodies - New Antibodies Could Lead to Generation of Interventions ...

The trading of TCE (T Cell Engager) bispecific antibodies remains hot, and multinational pharmaceutical companies (MNCs) are still placing orders frantically.Recently ...